2016 ASCO Annual Meeting - ASCO


Powered by SmugMug Log In
Jeeyun Lee, MD, PhD, reviews the current status of targeted therapy in upper gastrointestinal tract cancer during HER2, VEGFR, and Beyond: Genomic Profiling of Upper Gastrointestinal Tract Cancers and the Future of Personalized Treatment

Jeeyun Lee, MD, PhD, reviews the current status of targeted therapy in upper gastrointestinal tract cancer during HER2, VEGFR, and Beyond: Genomic Profiling of Upper Gastrointestinal Tract Cancers and the Future of Personalized Treatment

Chicago, IL - 2016 ASCO Annual Meeting - Jeeyun Lee, MD, PhD, reviews the current status of targeted therapy in upper gastrointestinal tract cancer during HER2, VEGFR, and Beyond: Genomic Profiling of Upper Gastrointestinal Tract Cancers and the Future of Personalized Treatment at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Friday, June 3, 2016. Over 30,000 physicians, researchers, and healthcare professionals from over 100 countries are attending the 52nd Annual Meeting which is being held at the McCormick Place convention center. The Annual Meeting highlights the latest findings in all major areas of oncology from basic through clinical and epidemiological studies. Photo by © ASCO/Danny Morton 2016 Technical Questions: todd@medmeetingimages.com; ASCO Contact: corpcomm@asco.org